title: Epilepsy in Rett syndrome---the experience of a National Rett Center.
abstract: OBJECTIVE
  Rett syndrome (RTT), an X-linked, dominant neurodevelopmental disorder caused by mutations in the methyl-CpG-binding protein 2 (MECP2) gene, presents with acquired microcephaly, autistic regression, hand usage loss, and stereotypies. Epilepsy is frequent and has been reported to correlate with mutation type, general disease severity, and BDNF polymorphism. Our purpose was a comprehensive description of epilepsy features and course in RTT.
  
  
  METHODS
  Retrospective review of charts and electroencephalography (EEG) studies in 97 patients with RTT.
  
  
  RESULTS
  Seventy-two percent of patients had epilepsy, appearing at a median age of 3 years. According to age of onset, we divided patients into three groups: 6 with early epileptic variant (0-1 year), 42 with early epilepsy (1-5 years), and 20 with late epilepsy (after 5 years). Early epileptic variant had severe seizure types in the first year of life, followed by a typical RTT picture; all were MECP2 negative. Early epilepsy and late epilepsy groups were similar with respect to Rett-related symptoms, but seizures were better controlled in the second group (p < 0.05). Epileptiform activity appeared earlier and was more confluent in the early epilepsy group, including nine patients with electrical status epilepticus during sleep (ESES) versus one in the late epilepsy group (p < 0.05). No correlation was found between epilepsy onset or severity and genotype. BDNF val/met polymorphism correlated with earlier onset of seizures (p < 0.05).
  
  
  CONCLUSIONS
  Epilepsy appears earlier than described previously, frequently during the regression stage. Early age of onset predicts a more severe course of seizures. ESES is common among those with early onset epilepsy. BDNF polymorphism was the only genetic correlate with seizure onset, whereas MECP2 mutation type and location did not influence epilepsy.
authors.affiliation: Pediatric Neurology Unit, Safra Children Hospital, Tel Ha Shomer, Israel.
authors.forename: Andreea
authors.initials: A
authors.lastname: Nissenkorn
authors.forename: Eva
authors.initials: E
authors.lastname: Gak
authors.forename: Manuela
authors.initials: M
authors.lastname: Vecsler
authors.forename: Haia
authors.initials: H
authors.lastname: Reznik
authors.forename: Shay
authors.initials: S
authors.lastname: Menascu
authors.forename: Bruria
authors.initials: B
authors.lastname: Ben Zeev
mesh_terms: D000046:Academic Medical Centers / Q000379:methods; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004569:Electroencephalography / Q000379:methods; D004827:Epilepsy / Q000209:etiology* / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007223:Infant; D007557:Israel; D008297:Male; D051783:Methyl-CpG-Binding Protein 2 / Q000235:genetics; D009154:Mutation; D011110:Polymorphism, Genetic; D012189:Retrospective Studies; D015518:Rett Syndrome / Q000150:complications* / Q000235:genetics* / Q000503:physiopathology; D055815:Young Adult
chemical_list: D019208:Brain-Derived Neurotrophic Factor; C497392:MECP2 protein, human; D051783:Methyl-CpG-Binding Protein 2